News results: "Acomplia"

« 11 results in "Health"« 1 results in "Specials"
dotclear

Health

Pfizer, Sanofi-Avensis End Studies on Diet Drugs

Pfizer Inc.and Sanofi-Aventis on Wednesday separately announced their decision to cancel further...
» read full story November 07th, 2008 - 16:00
Pfizer Halts Phase III Trial On Obesity Drug Over US Rejection Fears

Pfizer Halts Phase III Trial On Obesity Drug Over US Rejection Fears

Pfizer Inc., the world’s largest drugmaker, on Wednesday said it abandoned an obesity drug known...
» read full story November 06th, 2008 - 14:30
Anti-Obesity Drug Pulled From European Markets

Anti-Obesity Drug Pulled From European Markets

On Thursday, the French pharmaceutical company Sanofi-Aventis halted the sales of their...
» read full story October 24th, 2008 - 16:00
Sales of Sanofi’s Anti-Obesity Drug Acomplia Suspended In Europe

Sales of Sanofi’s Anti-Obesity Drug Acomplia Suspended In Europe

Warnings about Sanofi-Aventis’ anti-obesity rimonabant (Acomplia) had always accompanied the drug,...
» read full story October 24th, 2008 - 15:30
Merck’s Discontinuation On Taranabant Development

Merck’s Discontinuation On Taranabant Development

Merck & Co. has decided to bring to an end the development the experimental obesity drug...
» read full story October 05th, 2008 - 16:16
Merck Cancels Further Examination into Its Experimental Obesity Drug Taranabant

Merck Cancels Further Examination into Its Experimental Obesity Drug Taranabant

Merck & Co. on Thursday announced its decision to cancel further investigation into its...
» read full story October 03rd, 2008 - 16:30
Farewell To Development Of Obesity Drug Taranabant

Farewell To Development Of Obesity Drug Taranabant

Merck halted the research of the experimental obesity drug taranabant because of the dangerous side...
» read full story October 03rd, 2008 - 14:01
Merck’s Taranabant, another Obesity Drug with Psychiatric Side Effects

Merck’s Taranabant, another Obesity Drug with Psychiatric Side Effects

Merck Research Laboratories developed a new drug, called taranabant, which helped people shed...
» read full story January 09th, 2008 - 11:35
Sanofi-Aventis SA Faces Challenges on Acomplia

Sanofi-Aventis SA Faces Challenges on Acomplia

Sanofi-Aventis SA faces new challenges on its obesity drug Acomplia, after alarming studies were...
» read full story November 19th, 2007 - 13:05
EU Health Officials Warn About Weight-Loss Drug

EU Health Officials Warn About Weight-Loss Drug

A European health watchdog has warned that taking weight-loss drug Acomplia bears a risk of...
» read full story July 20th, 2007 - 19:51
FDA Warns About Acomplia, The Weight Loss Pill

FDA Warns About Acomplia, The Weight Loss Pill

A diet-pill developed by Sanofi-Aventis may trigger suicidal behavior and suicidal behavior and...
» read full story June 12th, 2007 - 17:45
dotclear

Specials

Anti-Obesity Drug Acomplia Gets Suspended in Europe

Anti-Obesity Drug Acomplia Gets Suspended in Europe

The European Medicines Agency wants Sanofi-Aventis SA’s anti-obesity drug Acomplia out of the...
» read full story October 24th, 2008 - 16:50
dotclear
dotclear
dotclear
Photos Gallery
dotclear